Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Peccatori

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Bone Marrow Transplantation|February 8, 2011
Combining allografting with mTOR inhibitors for metastatic renal cell cancerM Bregni, G Vitali, J Peccatori
Haematologica|October 17, 2001
Thalidomide and thrombosis in patients with multiple myelomaL Camba, J Peccatori, A Pescarollo, et al.
Bone Marrow Transplantation|February 24, 2009
Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allograftingM Bregni, M Bernardi, P Servida, et al.
Bone Marrow Transplantation|June 4, 2015
Haploidentical HSCT: a 15-year experience at San RaffaeleC Bonini, J Peccatori, M T L Stanghellini, et al.
Bone Marrow Transplantation|April 29, 2018
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamideA Mussetti, C De Philippis, C Carniti, et al.
Bone Marrow Transplantation|January 10, 2006
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancerM Bregni, K Fleischhauer, M Bernardi, et al.
Bone Marrow Transplantation|November 14, 2017
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinomaR Crocchiolo, O Ringden, J-O Bay, et al.
Bone Marrow Transplantation|July 9, 2009
Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplantsA Bacigalupo, T Lamparelli, G Milone, et al.
Bone Marrow Transplantation|December 8, 2015
Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapseE Xue, C Tresoldi, E Sala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignanciesA Zambelli, D Lilleri, P Pedrazzoli, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Bone Marrow Transplantation|February 8, 2011
Combining allografting with mTOR inhibitors for metastatic renal cell cancerM Bregni, G Vitali, J Peccatori
Haematologica|October 17, 2001
Thalidomide and thrombosis in patients with multiple myelomaL Camba, J Peccatori, A Pescarollo, et al.
Bone Marrow Transplantation|February 24, 2009
Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allograftingM Bregni, M Bernardi, P Servida, et al.
Bone Marrow Transplantation|June 4, 2015
Haploidentical HSCT: a 15-year experience at San RaffaeleC Bonini, J Peccatori, M T L Stanghellini, et al.
Bone Marrow Transplantation|April 29, 2018
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamideA Mussetti, C De Philippis, C Carniti, et al.
Bone Marrow Transplantation|January 10, 2006
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancerM Bregni, K Fleischhauer, M Bernardi, et al.
Bone Marrow Transplantation|November 14, 2017
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinomaR Crocchiolo, O Ringden, J-O Bay, et al.
Bone Marrow Transplantation|July 9, 2009
Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplantsA Bacigalupo, T Lamparelli, G Milone, et al.
Bone Marrow Transplantation|December 8, 2015
Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapseE Xue, C Tresoldi, E Sala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignanciesA Zambelli, D Lilleri, P Pedrazzoli, et al.
Pageof 3